5 Healthcare Trends to Invest in for the Next 20 Years
Our contributors think that healthcare-focused investors should watch these 5 long-term healthcare trends.
Generic Copaxone Isn't Derailing Teva Pharmaceuticals...Yet
Revenue from Copaxone has yet to fall dramatically following this year's approval of a generic version of the widely used MS therapy.
GlaxoSmithKline's Diverging Q3 Results Imply a Long Road to Recovery
GlaxoSmithKline's third-quarter results topped estimates, but the pharmaceutical giant is still facing quite the uphill battle.